CHICAGO — The duration of symptoms before surgery for degenerative cervical myelopathy (DCM) plays a key role in the quality of the outcome, underscoring the need for increased awareness among ...
At Toronto Western Hospital, neurosurgeon Dr. Michael Fehlings frequently encounters patients with degenerative cervical myelopathy (DCM), whose disabilities might have been avoided, if only they had ...
Degenerative cervical myelopathy (DCM) is a clinical condition of upper motor neuron lesion signs, that is confirmed with advanced imaging demonstrating compression of the spinal cord in the cervical ...
In August 2018, MediciNova, Inc. (MNOV) announced plans to conduct a Phase 2/3 trial of MN-166 in degenerative cervical myelopathy (DCM) through an agreement with the University of Cambridge and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback